141 related articles for article (PubMed ID: 29301572)
1. Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France.
Huguet M; Perrier L; Bally O; Benayoun D; De Saint Hilaire P; Beal Ardisson D; Morelle M; Havet N; Joutard X; Meeus P; Gabelle P; Provençal J; Chauleur C; Glehen O; Charreton A; Farsi F; Ray-Coquard I
BMC Health Serv Res; 2018 Jan; 18(1):3. PubMed ID: 29301572
[TBL] [Abstract][Full Text] [Related]
2. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery.
Timmermans M; Schuurman MS; Ho VKY; Massuger LF; Nijman HW; van Gorp T; Sonke GS; Kruitwagen RFPM; van der Aa MA
Gynecol Oncol; 2018 Jan; 148(1):56-61. PubMed ID: 29129391
[TBL] [Abstract][Full Text] [Related]
3. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
[TBL] [Abstract][Full Text] [Related]
4. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer.
Zwakman N; van de Laar R; Van Gorp T; Zusterzeel PL; Snijders MP; Ferreira I; Massuger LF; Kruitwagen RF
J Gynecol Oncol; 2017 Jan; 28(1):e7. PubMed ID: 27670261
[TBL] [Abstract][Full Text] [Related]
5. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing clinical trial enrollment among ovarian cancer patients.
Greenwade MM; Moore KN; Gillen JM; Ding K; Rowland MR; Crim AK; Kleis B; Gunderson CC
Gynecol Oncol; 2017 Sep; 146(3):465-469. PubMed ID: 28689668
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective.
Elstrand MB; Sandstad B; Oksefjell H; Davidson B; Tropé CG
Acta Obstet Gynecol Scand; 2012 Mar; 91(3):308-17. PubMed ID: 22050605
[TBL] [Abstract][Full Text] [Related]
8. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
9. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
Bristow RE; Palis BE; Chi DS; Cliby WA
Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
[TBL] [Abstract][Full Text] [Related]
10. The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.
Zhu J; Wang H; Liu CC; Lu Y; Tang H
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2339-45. PubMed ID: 27566683
[TBL] [Abstract][Full Text] [Related]
11. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
13. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
Solmaz U; Mat E; Dereli ML; Turan V; Peker N; Tosun G; Dogan A; Adiyeke M; Ozdemir A; Gungorduk K; Sanci M; Yildirim Y
J BUON; 2015; 20(3):847-54. PubMed ID: 26214639
[TBL] [Abstract][Full Text] [Related]
14. Histopathology predicts clinical outcome in advanced epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and debulking surgery.
Muraji M; Sudo T; Iwasaki S; Ueno S; Wakahashi S; Yamaguchi S; Fujiwara K; Nishimura R
Gynecol Oncol; 2013 Dec; 131(3):531-4. PubMed ID: 24096109
[TBL] [Abstract][Full Text] [Related]
15. Centralisation of epithelial ovarian cancer surgery: results on survival from a peripheral teaching hospital.
van Vliet MM; Schreuder HW; Pasker-de Jong PC; Duk MJ
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():72-8. PubMed ID: 26177496
[TBL] [Abstract][Full Text] [Related]
16.
González García B; García Vicente AM; Jiménez Londoño GA; Pena Pardo FJ; Bellón Guardia ME; Talavera Rubio MP; Palomar Muñoz A; Gómez Herrero P; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):233-240. PubMed ID: 28284928
[TBL] [Abstract][Full Text] [Related]
17. Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas.
Horng HC; Lai CR; Chang WH; Wen KC; Chen YJ; Juang CM; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):547-51. PubMed ID: 25510699
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy.
Nishimura S; Tsuda H; Kataoka F; Arao T; Nomura H; Chiyoda T; Susumu N; Nishio K; Aoki D
Hum Pathol; 2011 Apr; 42(4):516-21. PubMed ID: 21237490
[TBL] [Abstract][Full Text] [Related]
19. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population.
Forde GK; Chang J; Ziogas A; Tewari K; Bristow RE
Gynecol Oncol; 2015 Jun; 137(3):479-84. PubMed ID: 25866323
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer.
Rauh-Hain JA; Foley OW; Winograd D; Andrade C; Clark RM; Vargas RJ; Hinchcliff EM; Esselen KM; Horowitz NS; del Carmen MG
Am J Obstet Gynecol; 2015 May; 212(5):600.e1-8. PubMed ID: 25514761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
